Antidote-mediated control of an anticoagulant aptamer in vivo
Top Cited Papers
- 17 October 2004
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 22 (11) , 1423-1428
- https://doi.org/10.1038/nbt1023
Abstract
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.Keywords
This publication has 30 references indexed in Scilit:
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesJAMA, 2004
- Coronary Atherosclerotic Disease Burden: An Emerging Endpoint in Progression / Regression Studies Using Intravascular UltrasoundCurrent Drug Targets - Cardiovascular & Hematological Disorders, 2003
- Biochemistry and clinical pharmacology of new anticoagulant agentsPathophysiology of Haemostasis and Thrombosis, 2002
- RNA aptamers as reversible antagonists of coagulation factor IXaNature, 2002
- Generation of Species Cross-reactive Aptamers Using “Toggle” SELEXMolecular Therapy, 2001
- Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcomeTransfusion, 1999
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999
- Selective anticoagulation with active site-blocked factor IXa suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Liposome-Anchored Vascular Endothelial Growth Factor AptamersBioconjugate Chemistry, 1998
- Rat model of arterial thrombosis induced by ferric chlorideThrombosis Research, 1990